The FDA has given its first approval to an interactive digital inhaler sensor that allows patients to manage their condition by providing instructions and recording usage data.
List view / Grid view
chronic obstructive pulmonary disease (COPD)
Filter the results
AstraZeneca’s new carbon emission plan includes a 100 percent electric vehicle fleet and a 50 million tree reforestation plan.
A pharmaceutical company has announced its intention to create a pressurised Metered Dose Inhaler that will reduce the carbon footprint of the drug delivery system.
Adopting IoT systems as a pharmaceutical company can provide many opportunities but achieving success can be difficult. James Steiner explains how to effectively integrate IoT solutions into pharma.
The FDA has given a complete response letter to AstraZeneca for its PT010 treatment, regarding its New Drug Application.
The seven centres will aid disease research and clinical development, improving access to patient data for studies.
A clinical trial to study a chronic obstructive pulmonary disease treatment has found that the drug is effective and safe.